Molecular Insight Pharmaceuticals' IPO

Molecular Insight Pharmaceuticals raised a round of funding on February 03, 2007. Investors include Public.

Molecular Insight is a clinical-stage biopharmaceutical company focused on the critical unmet diagnostic and therapeutic needs of the prostate cancer patient. The Company is targeting the development …

Articles about Molecular Insight Pharmaceuticals' IPO: